Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
about
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityIntrathecal baclofen for treating spasticity in children with cerebral palsyA systematic review protocol to evaluate the psychometric properties of measures of function within adult neuro-rehabilitationIncidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review.Clinical study of botulinum toxin A injection combined with spasmodic muscle therapeutic instrument on lower limb spasticity in patients with stroke.Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to onabotulinumtoxinA and task practice therapy: a single-blind, randomized controlled pilot study.Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.Botulinum toxin type A treatment in neurogenetic syndromes.Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity.The role of botulinum toxin injections in the management of muscle overactivity of the lower limb.Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections.Botulinum toxin type A for upper limb spasticity after stroke.Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis.Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review.The efficacy of Botulinum Toxin A for limb spasticity on improving activity restriction and quality of life: a systematic review and meta-analysis using the GRADE approach.Do clinical tests of spasticity accurately reflect muscle function during walking: A systematic review.Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.Neurologic uses of botulinum neurotoxin type A.Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients.Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.Botulinum toxin injection in patients with hereditary spastic paraparesis.Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.The construct validity of a spasticity measurement device for clinical practice: an alternative to the Ashworth scales.Full-movement neuromuscular electrical stimulation improves plantar flexor spasticity and ankle active dorsiflexion in stroke patients: a randomized controlled study.Arm Activity measure (ArmA) application for recording functional gain following focal spasticity treatment
P2860
Q24202197-FFFFEDF2-0438-4EC0-B927-9A538530968AQ24247608-539A3824-874B-4879-AF21-87678E9DAEBCQ28082115-109C483E-ADDC-43CC-A148-7A50E7E11E33Q30252149-E90EAF66-8F9B-4BE4-A75F-607CB33282EFQ33744237-2CE36D3E-895C-46C2-9938-26E2977809EBQ33894347-79237CF3-65E8-4FF3-A320-8C37FF794808Q35478000-25512D3C-5E1B-489C-A64F-6BA6AD133F1EQ35893680-F022211B-5273-4F63-8D6C-6438041B0B5BQ36271388-D1538C90-29B8-490A-8C53-7659B5D83738Q36567918-03341EC4-4594-4126-84BE-B64F578528A2Q37011519-EE60C907-1650-45CD-92A4-2CD4249D7C09Q37089107-4C3B51F5-46EB-40C9-83E8-9AEA8F39CC63Q37596170-9F374E19-4F01-44B3-92E9-F82E07B28616Q37641993-A979083F-3950-4C75-90A3-62ED31EE9DF8Q37759065-589179CF-7C1D-412A-B272-C79E8D2C880BQ37765760-650228F0-F1CC-48BA-AFE3-783E49896730Q38263487-F6EAE1E4-A79F-47EC-904E-1AB8167E69E5Q38316027-8C71CFC8-DC51-4E46-9E7F-14C4B5F9686DQ38543439-67B790CB-EA6F-4B72-868D-AFCC24F79DD2Q38925041-B2B5326E-7646-4402-A724-15CD86A07FDFQ39446871-81A87612-7B77-439D-905E-162055DF29DFQ42086848-B5C1C4B6-F786-477C-8753-A574FE7A127AQ44608563-1AF067A7-92DE-434D-B721-9639380C3231Q47431627-8143B2A2-4A27-418C-8D63-00A04332A616Q47585173-E3B76948-1C04-4817-AC7D-0C16AE866BC6Q47815397-8FFE7AFD-77CD-4CDE-81DF-B2C940CCD243Q48347693-2682ADD3-EB54-47BA-A8CD-9F37C0470DE5Q51204041-E70DD6C2-F6E2-468A-B1A7-6549A109ACBAQ53378427-B8E39DFB-B1E9-4773-875D-9544F2CD6F14Q57466784-4ABCA798-C2F5-4478-BF51-2BB06E06D9FD
P2860
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@ast
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@en
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@nl
type
label
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@ast
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@en
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@nl
prefLabel
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@ast
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@en
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@nl
P1476
Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?
@en
P2093
P304
P356
10.1097/00019052-200112000-00015
P577
2001-12-01T00:00:00Z